Evogliptin, a dpp-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice

HIGHLIGHTS

• who: Trong Kha Pham from the Eight-week-old male diabetic db/db mice (BKSCg-Dock7m+/+ Leprdb/J) and eight-week-old male nondiabetic db/m+ mice (C BLKS/J) were purchased from Charles River (Japan). C BKS/J mice were used as normal controls or wild-type (WT) mice. All animals were housed in a specific pathogen-free facility with controlled temperature (20, u00b0C) and humidity (40-70%) on a , h light cycle with access to standard laboratory chow and tap water ad libitum. All experimental procedures were approved by the Inje Medical University Animal Care . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.